Conflict of interest and ethics policies

in page functions

Gavi's conflict of interest policy protects the integrity of Gavi's decision-making processes, particularly in regard to the allocation and disbursement of resources. The ethics policy ensures standards of ethical conduct for activities of any member of the Secretariat, Board and Advisory Bodies


The richness of the Vaccine Alliance lies in the involvement and participation of the main stakeholders to immunisation. For example, the Board's representative members ensure that institutions and constituencies can provide formal input into the development of all Gavi's policies and the management of its operations.

Together with independent board members, whose experience in the private sector bring an innovative perspective to discussions, Board members engage in a process of balanced strategic decision-making, innovation and partner collaboration.

Fiduciary responsibility

Though they bring their experience and affiliations to bear for the benefit of Gavi, Board members recognise they have a fiduciary responsibility to put the interests of Gavi before other interests when taking decisions on behalf of the Vaccine Alliance.

Concurrently, when discharging their duties, Representative Board Members are not required to take decisions that conflict with the constitution, regulations, rules and policies of the organisation providing that member to the Board.


As a result, Article 28 of the Gavi Statutes states the Board shall adopt a conflicts of interest policy for all organs of the Vaccine Alliance.

The purpose of this policy is to protect the reputation and integrity of Gavi's decision-making processes, particularly in regard to the allocation and disbursement of resources, by establishing procedures to identify, evaluate and address any real or potential conflicts that may arise from time to time.

In addition to Board members, members of the Secretariat and others involved in decision-making processes on behalf of Gavi will be expected to abide by the provisions of this policy.

Initially approved by the Board on 2-3 June 2009, the Governance Committee reviewed the policy in May 2012. The Board approved the revised Conflict of Interest policy on 12 June 2012.

Ethics policy

The Ethics policy, linked to the Conflict of Interest policy, was created to settle guidelines and principles of integrity and transparency. Reviewed by the Governance Committee in May 2012, the Board approved the Ethics policy on 12 June 2012.

US$ 80-100 billion

Investing in Gavi’s 2016-2020 strategy has the potential to deliver US$ 80-100 billion in costs averted related to illness, such as productivity loss due to death/disability, treatment costs, caretaker productivity loss and transport costs.

Stack M et al. Estimated economic benefits during Decade of Vaccines, Health Affairs 2011

More facts...

close icon

modal window here